Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis

77Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

Abstract

Objective. We previously described a novel radiolabelled monoclonal antibody (1.2B6), which reacts with porcine E-selectin, for targeting activated endothelium as a means of imaging inflammatory disorders, and presented initial clinical work based on 111In-labelled antibody. The aim of the present study was to evaluate a Fab fragment of 1.2B6 labelled with 99mTc in patients with rheumatoid arthritis (RA) by comparison with (i) 111In-labelled 1.2B6 F(ab′)2 and (ii) conventional bone scanning. Methods. 99mTc-1.2B6-Fab (∼ 440 MBq) and 111In-1.2B6-F(ab′)2 (∼ 27 MBq) were compared in 10 patients using a double-isotope protocol. Images were obtained 4 and 20-24 h after injection. Two normal volunteers were also imaged. In a separate group of 16 patients, 99mTc-1.2B6-Fab and 99mTc-oxidronate (99mTc-HDP) ( ∼ 740 MBq) were compared on the basis of visual and semi-quantitative analysis of joint uptake (joint/soft tissue ratios) 4 h after injection. The respective biodistributions and blood clearances of the two 1.2B6 fragments were also compared. Results. Image contrast was slightly better with 99mTc-Fab at 4 h but equal for the two tracers at 24 h. Diagnostic accuracy, taking joint tenderness or swelling as the clinical endpoint, was 76% for both fragments at 24 h. Plasma clearance of 99mTc-Fab was faster than that of 111In-F(ab′)2 (t1/2 142 vs 421 min; P < 0.0001). 99mTc-Fab appeared somewhat unstable in vivo, as shown by activity in the thyroid gland and bowel. The diagnostic accuracy of 99mTc-Fab was 88%, higher than that of 99mTc-HDP (57%) as a result of the low specificity of the latter in RA. Receiver operating characteristic (ROC) curve analysis using joint/soft tissue ratios as a variable cut-off showed that 99mTc-Fab discriminates better than 99mTc-HDP between actively inflamed and silent joints (Z = 4.72; P < 0.0001). No uptake of 99mTc-Fab was observed by inactive or normal joints, whereas 99mTc-HDP was taken up by all joints to a variable degree, making the decision as to whether a particular joint is actively involved or chronically damaged very difficult. Conclusion. 99mTc-anti-E-selectin-Fab scintigraphy can be used successfully to image synovitis with better specificity than 99mTc-HDP bone scanning. The advantages over 111In-1.2B6-F(ab′)2 are easier availability of the radionuclide, improved physical properties and optimal imaging 4 h after injection.

Cite

CITATION STYLE

APA

Jamar, F., Houssiau, F. A., Devogelaer, J. P., Chapman, P. T., Haskard, D. O., Beaujean, V., … Peters, A. M. (2002). Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis. Rheumatology, 41(1), 53–61. https://doi.org/10.1093/rheumatology/41.1.53

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free